Drugs / Recombinant Factor VIII (rAHF)
Recombinant Factor VIII (rAHF)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00666406 Comparator | Mar 2008 → Feb 2009 | hemophilia A | Baxalta now part of Shire | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Factor VIII (rAHF) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00666406 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Factor VIII (rAHF)” NCT00666406 ↗ |